“…Individuals with short telomeres have a 3.18-fold higher mortality rates from heart diseases and 8.54-fold higher mortality rates from infectious diseases compared to those with relatively long telomeres but it is not a significant prognostic factor for survival above 85 years. In addition to telomere shortening with aging, accelerated shortening observed in PBMCs occurs in various human diseases such as myelodysplasic syndrome (Jiang et al, 2007;Andrews et al, 2010;Ohyashiki et al, 1999), atherosclerosis and hypertension (Jiang et al, 2007;Andrews et al, 2010;Benetos et al, 2004), coronary artery disease, human immunodeficiency virus, rheumatoid arthritis (Jiang et al, 2007;Andrews et al, 2010;Steer et al, 2007) systemic lupus erythematosus, cognitive decline,... (Jiang et al, 2007;Andrews et al, 2010). Alzheimer patients present reduced telomere length in PBMCs compared to control.…”